Xue Ding
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- RNA modifications and cancer
- Cancer-related gene regulation
- Circular RNAs in diseases
Papers in
-
- RNA modifications and cancer 4
- Cancer-related gene regulation 3
-
- Gastric Cancer Management and Outcomes 7
- Metastasis and carcinoma case studies 6
- Co-authors
- Xing Feng (2 shared papers)Huiwen Song (2 shared papers)Yun Luo (2 shared papers)Zhiyong Zhang (2 shared papers)Yongxiang Zhao (1 shared paper)He Huang (1 shared paper)Shu-Jing Wu (1 shared paper)Meihua Lin (1 shared paper)
- Journals
- Autophagy (2 papers)Cellular Physiology and Biochemistry (2 papers)Biochemical and Biophysical Research Communications (2 papers)Academic Radiology (1 paper)Industrial Crops and Products (1 paper)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Xue Ding
44 papers receiving 1.0k citations
Xue Ding's Hit Papers
Peers
Comparison fields: 5 of 95
- Cancer Research 279
- Molecular Biology 619
- Biochemistry 59
- Endocrine and Autonomic Systems 45
- Drug Discovery 1
Countries citing papers authored by Xue Ding
This map shows the geographic impact of Xue Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xue Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xue Ding more than expected).
Fields of papers citing papers by Xue Ding
This network shows the impact of papers produced by Xue Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xue Ding. The network helps show where Xue Ding may publish in the future.
Co-authors
The 25 scholars most cited alongside Xue Ding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | METTL3 and ALKBH5 oppositely regulate m6A modification of TFEB mRNA, which dictates the fate of hypoxia/reoxygenation-treated cardiomyocytes Hit paper breakdown → | 2019 | 388 |
| 2 | 2015 | 105 | |
| 3 | 2021 | 86 | |
| 4 | 2014 | 43 | |
| 5 | 2014 | 41 | |
| 6 | 2009 | 39 | |
| 7 | 2018 | 39 | |
| 8 | 2020 | 35 | |
| 9 | 2016 | 31 | |
| 10 | 2015 | 25 | |
| 11 | 2014 | 20 | |
| 12 | 2016 | 19 | |
| 13 | 2020 | 19 | |
| 14 | 2016 | 15 | |
| 15 | 2014 | 14 | |
| 16 | 2023 | 13 | |
| 17 | 2019 | 10 | |
| 18 | 2019 | 10 | |
| 19 | 2015 | 9 | |
| 20 | 2022 | 7 |
About Xue Ding
Xue Ding is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Surgery, Cardiology and Cardiovascular Medicine and Oncology, having authored 47 papers that have together received 1.0k indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (7 papers), Metastasis and carcinoma case studies (6 papers), Antiplatelet Therapy and Cardiovascular Diseases (4 papers), RNA modifications and cancer (4 papers), Cell Adhesion Molecules Research (3 papers), Cancer-related gene regulation (3 papers), Obstructive Sleep Apnea Research (3 papers) and MicroRNA in disease regulation (3 papers). The work is most often cited by research in Cancer Research (279 citations), Molecular Biology (619 citations), Biochemistry (59 citations), Endocrine and Autonomic Systems (45 citations) and Drug Discovery (1 citation). Xue Ding has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Xing Feng, Huiwen Song, Yun Luo, Zhiyong Zhang, Yongxiang Zhao, He Huang, Shu-Jing Wu, Meihua Lin, Juan Huang and Tian Yu. Their work appears in journals such as Autophagy, Cellular Physiology and Biochemistry, Biochemical and Biophysical Research Communications, Academic Radiology and Industrial Crops and Products.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.